Market Closed -
Other stock markets
|
Pre-market 06:30:10 pm | |||
128.8 USD | -0.31% | 130.5 | +1.30% |
May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
May. 01 | Redburn Atlantic Adjusts Price Target on Merck to $148 From $142 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.16% | 327B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B | |
-5.59% | 145B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck : Bristol-Myers To Shed Acceleron Stake Ahead Of Merck & Co.'s $11.5 Billion Acquisition